Participated · Series A · Jul 2026

Flourish Health delivers intensive in-home mental health care for children and young adults through psychiatrist-led Care Pods composed of a child and adolescent psychiatrist, a licensed therapist, a patient guide, and a family guide. The company built a proprietary technology platform that integrates patient touchpoints, EMR and prescribing capabilities, workflow automation, team collaboration, and AI to support engagement and coordination while clinicians make clinical decisions. Flourish specializes in three clinical populations: children with externalizing behaviors, young people with multiple suicide attempts or suicide-related hospitalizations, and patients with complex needs and family situations often turned away by other clinics. Studies run with multiple major health plans report large reductions in hospitalization (70–96%), residential treatment (69–90%), and sustained decreases in higher levels of care post-discharge (80–95%). Flourish commits to beginning care within one week of referral, reports 92% month-over-month retention during its 12-month programs, and says those programs cost less than one month of inpatient treatment.

Participated · Seed · Jun 2026

Kestrel Labs builds an AI-powered compliance platform that integrates directly inside Building Information Modeling (BIM) workflows, notably Autodesk Revit. Its product suite includes Kestrel Compliance Analysis (one-click model checks with element-level results and code citations), Kestrel Compliance Chat (an AI building code assistant that cites exact code sections), and the Kestrel Portal (a web dashboard for project and firm leaders). The company draws compliance content from an agreement with the International Code Council (ICC). Kestrel emphasizes an annual firm-wide licensing model with no per-seat fees and charter-customer preferred pricing. Founders Austin Pulford (AIA, NCARB) and Marian Pulford (Co-Founder and CEO) built the product from their domain experience in licensed architectural practice. The company is located in Denver, Colorado.

Participated · Series A · Apr 2026

Keebler Health builds an LLM-native platform that processes unstructured clinical documentation at scale to surface missed hierarchical condition category (HCC) coding opportunities and deliver actionable clinician insights at the point of care. The platform targets both retrospective and concurrent workflows to enable appropriate revenue capture without disrupting existing clinical operations. Keebler positions risk adjustment as its initial focus while planning to expand into broader population health use cases, Next Best Diagnostic Action, and compliance/audit workflows such as RADV audit readiness. The company was founded in 2023 by Isaac Park, Andrew Stickney, and Kevin Hill, PhD, with Terrell Bacchus, MD as founding CMO, and is headquartered in Durham, North Carolina. Financially, Keebler has raised $23 million to date, including the $16 million Series A announced in this round.

Led · Seed · Mar 2026

Earlyasset is building a platform intended to provide pricing transparency, transaction infrastructure, and access to capital for the venture secondary market. The company plans to launch its platform later this year, enabling early users to register private holdings, access pricing insights, and request liquidity. Earlyasset is led by co-founder and CEO Shawn Bercuson and is based in Park City, Utah. It raised $2 million in a pre-seed round led by New Stack Ventures, with participation from Cervin Ventures, Andrew Ryan of ABVCS, and angel investors. The company said it will use the funding to expand operations and accelerate development efforts. As it builds out its network of investors and capital partners, Earlyasset aims to expand liquidity across private markets.

Participated · Seed · Feb 2026

Very little public information is available about Maestro Tech, Inc. beyond its recent financing activity. The company announced a $1.2 million pre-seed round, indicating that it is still in the product-development or market-validation phase. Investors in the round include New Stack Ventures, Family VC, ZFO, Roark's Drift, and several unnamed angel investors. No specifics regarding the company’s core product, target market, revenue, user base, or future roadmap were disclosed in the source material. The fresh capital will likely be used to fund initial product development, early hiring, and go-to-market experimentation, but the company has not publicly confirmed any such plans. Key operating metrics, geographic headquarters, and founding date were not provided. Consequently, the company’s current financial situation beyond the new capital infusion remains undisclosed.